Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  DELIVERABLE VOLUME
Deliverable Volume      
Alembic Pharmaceuticals Ltd.
BSE Code 533573
ISIN Demat INE901L01018
Book Value 264.28
NSE Code APLLTD
Dividend Yield % 1.13
Market Cap 190980.73
P/E 37.96
EPS 25.60
Face Value 2  
Exchange : Period From : Period To :
DateTotal VolumeDeliverable VolumeDeliverable Volume [%]
25-Jun-2025 2238 972 43.43
24-Jun-2025 7280 3077 42.27
23-Jun-2025 7074 3729 52.71
20-Jun-2025 3693 1318 35.69
19-Jun-2025 6902 2883 41.77
18-Jun-2025 11858 1656 13.97
17-Jun-2025 9885 1341 13.57
16-Jun-2025 9999 4958 49.58
13-Jun-2025 3525 1572 44.60
12-Jun-2025 4317 1837 42.55
11-Jun-2025 4512 2739 60.70
10-Jun-2025 3741 1006 26.89
09-Jun-2025 2665 1762 66.12
06-Jun-2025 2169 1257 57.95
05-Jun-2025 2453 1301 53.04
04-Jun-2025 1942 968 49.85
03-Jun-2025 3558 2047 57.53
02-Jun-2025 7347 2597 35.35
Page 1 of 1
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.